Viewing StudyNCT05132101



Ignite Creation Date: 2024-05-06 @ 4:55 PM
Last Modification Date: 2024-10-26 @ 2:18 PM
Study NCT ID: NCT05132101
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2023-04-10
First Post: 2021-11-11

Brief Title: Analysis of the Real-world Prescription Pattern of Palbociclib Combination Therapy With Aromatase Inhibitor as a First Line Therapy in Metastatic Breast Cancer Patients Using the National Health Insurance Claims Data in South Korea
Sponsor: Pfizer
Organization: Pfizer

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-12-20
Start Date Type: ACTUAL
Primary Completion Date: 2023-06-30
Primary Completion Date Type: ESTIMATED
Completion Date: 2023-06-30
Completion Date Type: ESTIMATED
First Submit Date: 2021-11-11
First Submit QC Date: November 11 2021
Study First Post Date: 2021-11-24
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-04-06
Last Update Post Date: 2023-04-10
Last Update Post Date Type: ACTUAL